Definium Therapeutics, Inc.
Status: Publicly traded
Direct answer
Definium Therapeutics, Inc. is publicly traded on NASDAQ under the ticker DFTX.
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another...
Can you invest in Definium Therapeutics, Inc.?
Yes. Definium Therapeutics, Inc. is publicly traded on NASDAQ under the ticker DFTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Definium Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.